An official website of the United States government
Rates* of reported cases† of acute hepatitis C, by state or jurisdiction — United States, 2021–2022
Source: CDC, National Notifiable Diseases Surveillance System.
* Rates per 100,000 population.
† Reported confirmed cases. For the case definition, see Acute Hepatitis C.
Only states with rates for 2022 and 2021 are shown. State/jurisdiction and year for no reported cases: Hawaii (2022, 2021), Idaho (2021), New Mexico (2021), North Dakota (2022, 2021), Vermont (2021); for not reportable condition: Alaska (2022, 2021); for unavailable data: Arizona (2022, 2021), District of Columbia (2021), Rhode Island (2021).
State or jurisdiction ranked in decreasing order by the 2022 rate, 2021 rate, and then alphabetical order by name.
During 2022, the rates of reported acute hepatitis C ranged from a high of 6.8 cases per 100,000 population in Maine to a low of 0.1 or fewer cases per 100,000 population in Mississippi, Texas, and South Carolina. The largest absolute increase was observed in South Dakota from 0.4 cases per 100,000 population in 2021 to 1.8 cases per 100,000 in 2022. The largest absolute decrease was observed in Delaware, where the rate of 1.7 cases per 100,000 population in 2022 was a 71% decrease from the rate of 5.8 cases per 100,000 population in 2021. Because of the relatively smaller number of acute hepatitis C cases reported in certain jurisdictions, wide fluctuations in annual rates might occur.
- Figure 3.1. Number of reported cases and estimated infections of acute hepatitis C — United States, 2015–2022
- Figure 3.2. Rates of reported cases of acute hepatitis C, by state or jurisdiction — United States, 2021–2022
- Figure 3.3. Rates of reported cases of acute hepatitis C, by state or jurisdiction — United States, 2022
- Figure 3.4. Rates of reported cases of acute hepatitis C, by age group — United States, 2007–2022
- Figure 3.5. Rates of reported cases of acute hepatitis C, by sex — United States, 2007–2022
- Figure 3.6. Rates of reported cases of acute hepatitis C, by race/ethnicity — United States, 2007–2022
- Figure 3.7. Availability of information on risk behaviors or exposures associated with reported cases of acute hepatitis C — United States, 2022
- Figure 3.8. Number of newly reported chronic hepatitis C cases by sex and age — United States, 2022
- Figure 3.9. Rates of deaths with hepatitis C listed as a cause of death among residents, by state or jurisdiction — United States, 2022
- Table 3.1. Numbers and rates of reported cases of acute hepatitis C, by state or jurisdiction — United States, 2018–2022
- Table 3.2. Numbers and rates of reported cases of acute hepatitis C, by demographic characteristics — United States, 2018–2022
- Table 3.3. Reported risk behaviors or exposures among reported cases of acute hepatitis C — United States, 2022
- Table 3.4. Number of newly reported cases of perinatal hepatitis C, by state or jurisdiction — United States, 2022
- Table 3.5. Number and rate of newly reported cases of chronic hepatitis C, by state or jurisdiction — United States, 2022
- Table 3.6. Number and rate of newly reported cases of chronic hepatitis C, by demographic characteristics — United States, 2022
- Table 3.7. Numbers and rates of deaths with hepatitis C listed as a cause of death among residents, by state or jurisdiction — United States, 2018–2022
- Table 3.8. Numbers and rates of deaths with hepatitis C listed as a cause of death among residents, by demographic characteristics — United States, 2018–2022